Pt | SL-BUP Administration | Procedure (Anesthetic Agents) Year of Surgery | Regional Anesthesia Type and Drugs | Surgery Time, min | Opioid Administration, IV-MEq | Highest VNPS¶ | ||||
---|---|---|---|---|---|---|---|---|---|---|
Daily SL-BUP Dose, mg† | Days without SL-BUPa | Intra- operative | PACU Only | 24 h after PACU Discharge | Total IV-MEq§ | |||||
Regional Anesthesia Only | ||||||||||
1 | 8 (2) | 0 | Cesarean section, 2012 | Spinalb (Bupiv+Fentanyl) | 57 | 12 | 74 | 133 | 219* | 10c |
2 | 8 (2) | 0 | Minor vascular, 2010 | Axillaryb (Mepiv) | 127 | 5 | 0 | 0 | 5 | NR |
3 | 16 (4)e | 2 | Major orthopedic, 2016 | Spinalb (Bupiv) | 94 | 15 | 0 | 74 | 89 | 9c |
Combined Regional + General Anesthesia | ||||||||||
1 | 2 (0.5)e | 0 | Thoracic (Iso), 2009 | Epidurald (Bupiv+Hydromor) | 110 | 39 | 30 | 134 | 203* | 10 |
2 | 4 (1) | 0 | Major orthopedic (Iso + N2O), 2014 | Interscalenef (Bupiv+Clon) | 93 | 30 | 18 | 53 | 100‡ | 9 |
3 | 16 (4)e | 0 | Major orthopedic (Iso + N2O), 2014 | Interscalene (Bupiv+Clon) | 70 | 15 | 20 | 38 | 73 | 8 |
4 | 16 (4) | 0 | Minor orthopedic (Pro), 2013 | Axillaryb (Bupiv) | 88 | 5 | 0 | 0 | 5 | NR |
5 | 16 (4) | 0 | Major orthopedic (Sevo+N2O), 2015 | Femoralf (Bupiv) | 168 | 40 | 10 | 94 | 143* | 10c |
6 | 24 (6) | 0 | Major orthopedic (Iso + N2O), 2014 | Interscalenef (Bupiv) | 60 | 5 | 13 | 420 | 437 | 9 |
7 | 32 (8) | 0 | Major orthopedic (Iso + N2O), 2011 | Epidurald (Bupiv) | 128 | 13 | 5 | 60 | 78* | 8c |
8 | 24 (6) | 2 | Major orthopedic (Des), 2011 | Psoase (Bupiv) | 74 | 10 | 40 | 0 | 50 | 4c |
9 | 24 (6) | 2 | Major orthopedic (Des), 2012 | Sciaticd + femorald (Bupiv) | 124 | 53 | 15 | 33 | 100 | 8 |
10 | 4 (1) | 4 | Major orthopedic (Iso + N2O), 2012 | Interscalenef (Bupiv) | 120 | 40 | 8 | 110 | 157 | 10c |
11 | 16 (4)e | 7 | Abdominal (Iso), 2014 | Spinalf (Hydromor) | 115 | 20 | 15 | 105 | 140* | 10c |
12 | 24 (6)e | 30 | Major orthopedic (Iso), 2013 | Interscalenef (Bupiv) | 93 | 25 | 0 | 241 | 266 | 10 |